Biogen emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/2025 | BIIB | Biogen | FY | 2025 | $14.50 | $15.00 | $15.70 | $9.68B | $9.77B | $9.68B | |
07/31/2025 | BIIB | Biogen | FY | 2025 | $15.50 | $16.00 | $14.69 | — | — | — | |
05/01/2025 | BIIB | Biogen | FY | 2025 | $14.50 | $15.50 | $15.20 | — | — | — | |
02/12/2025 | BIIB | Biogen | FY | 2025 | $15.25 | $16.25 | $16.24 | — | — | — | |
10/30/2024 | BIIB | Biogen | FY | 2024 | $16.10 | $16.60 | $16.19 | — | — | — | |
08/01/2024 | BIIB | Biogen | FY | 2024 | $15.75 | $16.25 | $15.58 | — | — | — | |
04/24/2024 | BIIB | Biogen | FY | 2024 | $15.00 | $16.00 | $15.46 | — | — | — | |
02/13/2024 | BIIB | Biogen | FY | 2024 | $15.00 | $16.00 | $15.65 | — | — | — | |
11/08/2023 | BIIB | Biogen | FY | 2023 | $14.50 | $15.00 | $15.29 | — | — | — | |
07/25/2023 | BIIB | Biogen | FY | 2023 | $15.00 | $16.00 | $15.42 | — | — | — | |
04/25/2023 | BIIB | Biogen | FY | 2023 | $15.00 | $16.00 | $15.48 | — | — | — | |
02/15/2023 | BIIB | Biogen | FY | 2023 | $15.00 | $16.00 | $15.72 | — | — | — | |
10/25/2022 | BIIB | Biogen | FY | 2022 | $16.50 | $17.15 | $16.49 | $10.00B | $10.15B | $10.00B | |
07/20/2022 | BIIB | Biogen | FY | 2022 | $15.25 | $16.75 | $15.54 | $9.90B | $10.10B | $9.84B | |
05/03/2022 | BIIB | Biogen | FY | 2022 | $14.25 | $16.00 | $15.44 | $9.70B | $10.00B | $9.87B | |
02/03/2022 | BIIB | Biogen | FY | 2022 | $14.25 | $16.00 | $18.85 | $9.70B | $10.00B | $10.34B | |
10/20/2021 | BIIB | Biogen | FY | 2021 | $18.85 | $19.35 | $18.61 | $10.80B | $10.90B | $10.76B | |
07/22/2021 | BIIB | Biogen | FY | 2021 | $17.50 | $19.00 | $18.59 | $10.65B | $10.85B | $10.63B | |
04/22/2021 | BIIB | Biogen | FY | 2021 | $17.50 | $19.00 | $18.41 | $10.45B | $10.75B | $10.57B |
La orientación más reciente para Biogen (BIIB) se informó el octubre 30, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $14.50 a $15.00, en comparación con el EPS estimado de $15.70. Además, Biogen pronosticó ingresos entre $9.68B y $9.77B para el trimestre.
Explora orientación y previsión sobre todos los valores.